{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:00:18Z","timestamp":1790100018994,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/ATGC\/127\/SP38429\/2020"],"award-info":[{"award-number":["BT\/ATGC\/127\/SP38429\/2020"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["45\/45\/2020-NAN\/BMS"],"award-info":[{"award-number":["45\/45\/2020-NAN\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jconrel.2023.01.085","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T22:53:40Z","timestamp":1676328820000},"page":"474-488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Intracranial nanomedicine-gel with deep brain-penetration for glioblastoma therapy"],"prefix":"10.1016","volume":"355","author":[{"given":"Devika","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanya","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjith","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genekehal Siddaramana","family":"Gowd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maneesh","family":"Manohar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thennavan","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip","family":"Panikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantikumar V.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manzoor","family":"Koyakutty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jconrel.2023.01.085_bb0005","first-page":"707","article-title":"Interstitial chemotherapy with biodegradable BCNU (Gliadel \u00ae) wafers in the treatment of malignant gliomas","volume":"3","author":"Bota","year":"2007"},{"issue":"14","key":"10.1016\/j.jconrel.2023.01.085_bb0010","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1517\/14656566.2014.947266","article-title":"Standard of care and future pharmacological treatment options for malignant glioma: An urgent need for screening and identification of novel tumor-specific antigens","volume":"15","author":"Batich","year":"2014","journal-title":"Expert. Opin. Pharmacother."},{"issue":"12","key":"10.1016\/j.jconrel.2023.01.085_bb0015","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/neuonc\/now086","article-title":"Multimodal imaging patterns predict survival in recurrent glioblastoma patients treated with bevacizumab","volume":"18","author":"Chang","year":"2016","journal-title":"Neuro-Oncology"},{"issue":"11","key":"10.1016\/j.jconrel.2023.01.085_bb0020","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s12094-016-1497-x","article-title":"Survival in glioblastoma: a review on the impact of treatment modalities","volume":"18","author":"Delgado-L\u00f3pez","year":"2016","journal-title":"Clin. Transl. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2023.01.085_bb0025","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ijpharm.2018.07.033","article-title":"Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival","volume":"548","author":"Zhao","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"19I","key":"10.1016\/j.jconrel.2023.01.085_bb0030","doi-asserted-by":"crossref","first-page":"6767","DOI":"10.1158\/1078-0432.CCR-05-0722","article-title":"Food and drug administration drug approval summary: Temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme","volume":"11","author":"Cohen","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.jconrel.2023.01.085_bb0035","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1200\/JCO.2002.20.5.1375","article-title":"Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide","volume":"20","author":"Stupp","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.jconrel.2023.01.085_bb0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11060-009-9857-9","article-title":"Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection","volume":"94","author":"Akbar","year":"2009","journal-title":"J. Neuro-Oncol."},{"issue":"10","key":"10.1016\/j.jconrel.2023.01.085_bb0045","doi-asserted-by":"crossref","first-page":"e876","DOI":"10.1038\/cddis.2013.388","article-title":"O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas","volume":"4","author":"Fan","year":"2013","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.jconrel.2023.01.085_bb0050","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"7","key":"10.1016\/j.jconrel.2023.01.085_bb0055","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0169-409X(02)00054-6","article-title":"Local drug delivery to the brain","volume":"54","author":"Wang","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2023.01.085_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12010175","article-title":"Polymeric nanoparticles for the treatment of malignant gliomas","volume":"12","author":"Mahmoud","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.jconrel.2023.01.085_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/wnan.1479","article-title":"Nanotherapeutic systems for local treatment of brain tumors","volume":"10","author":"Chakroun","year":"2018","journal-title":"Wiley Interdiscip Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2023.01.085_bb0070","series-title":"The Targeted Delivery of Cancer Drugs Across the Blood \u2013 Brain Barrier\u00a0: Chemical Modifications of Drugs or","volume":"13","author":"Juillerat-jeanneret","year":"2008"},{"issue":"8","key":"10.1016\/j.jconrel.2023.01.085_bb0075","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","article-title":"Drug resistance in brain diseases and the role of drug efflux transporters","volume":"6","author":"L\u00f6scher","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.jconrel.2023.01.085_bb0080","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejpb.2004.06.006","article-title":"Evaluation of in vitro and in vivo antitumor activity of BCNU-loaded PLGA wafer against 9L gliosarcoma","volume":"59","author":"Lee","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"8956","key":"10.1016\/j.jconrel.2023.01.085_bb0085","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0140-6736(95)90755-6","article-title":"Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas","volume":"345","author":"Brem","year":"1995","journal-title":"Lancet."},{"key":"10.1016\/j.jconrel.2023.01.085_bb0090","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijpharm.2019.01.042","article-title":"Drug combination using an injectable nanomedicine hydrogel for glioblastoma treatment","volume":"559","author":"Bastiancich","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2023.01.085_bb0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/neuonc\/5.2.79","article-title":"A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma","volume":"5","author":"Westphal","year":"2004","journal-title":"Neuro-Oncology"},{"issue":"2","key":"10.1016\/j.jconrel.2023.01.085_bb0100","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11060-015-1724-2","article-title":"Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis","volume":"122","author":"Chowdhary","year":"2015","journal-title":"J. Neuro-Oncol."},{"issue":"January","key":"10.1016\/j.jconrel.2023.01.085_bb0105","first-page":"1","article-title":"Theranostic 3-dimensional nano brain-implant for prolonged and localized treatment of recurrent glioma","volume":"7","author":"Ramachandran","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2023.01.085_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113951","article-title":"Rationally designed drug delivery systems for the local treatment of resected glioblastoma","volume":"177","author":"Bastiancich","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.jconrel.2023.01.085_bb0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3171\/jns.1983.58.2.0159","article-title":"Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme","volume":"58","author":"Burger","year":"1983","journal-title":"J. Neurosurg."},{"issue":"1","key":"10.1016\/j.jconrel.2023.01.085_bb0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0360-3016(92)91021-E","article-title":"Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment","volume":"24","author":"Gaspar","year":"1992","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.jconrel.2023.01.085_bb0125","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0360-3016(98)90036-0","article-title":"The fallacy of the localized supratentorial malignant glioma","volume":"15","author":"Halperin","year":"1988","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.jconrel.2023.01.085_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/2211068213499157","article-title":"Modeling mass transfer from Carmustine-loaded polymeric implants for malignant gliomas","volume":"19","author":"Pereira","year":"2014","journal-title":"J. Lab. Autom."},{"issue":"3","key":"10.1016\/j.jconrel.2023.01.085_bb0135","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1023\/B:NEON.0000014539.90077.db","article-title":"Pattern of recurrence following local chemotherapy with biodegradable carmustine (BCNU) implants in patients with glioblastoma","volume":"66","author":"Giese","year":"2004","journal-title":"J. Neuro-Oncol."},{"issue":"2","key":"10.1016\/j.jconrel.2023.01.085_bb0140","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1166\/jbn.2020.2747","article-title":"A polymer-protein core-shell nanomedicine for inhibiting cancer migration followed by photo-triggered killing (Journal of Biomedical Nanotechnology, Vol. 10(8), pp. 1401\u20131415 (2014))","volume":"16","author":"Ramachandran","year":"2020","journal-title":"J. Biomed. Nanotechnol."},{"issue":"August","key":"10.1016\/j.jconrel.2023.01.085_bb0145","first-page":"1","article-title":"Neuro-Oncology Advances the inhibition of glioma stem cells","volume":"3","author":"Manju","year":"2021"},{"key":"10.1016\/j.jconrel.2023.01.085_bb0150","doi-asserted-by":"crossref","DOI":"10.1007\/s13346-022-01142-5","article-title":"Enhanced oral bioavailability and antitumor therapeutic efficacy of sorafenib administered in core\u2013shell protein nanoparticle","author":"Gopakumar","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"issue":"12","key":"10.1016\/j.jconrel.2023.01.085_bb0155","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2217\/nnm-2020-0382","article-title":"Cancer nanomedicine developed from total human serum: a novel approach for making personalized nanomedicine","volume":"16","author":"Thayath","year":"2021","journal-title":"Nanomedicine."},{"issue":"2","key":"10.1016\/j.jconrel.2023.01.085_bb0160","first-page":"172","article-title":"Growth in the Rat 9L Flank Model","volume":"123","author":"Kim","year":"2017"},{"issue":"1","key":"10.1016\/j.jconrel.2023.01.085_bb0165","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jconrel.2011.11.031","article-title":"Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers","volume":"159","author":"Wolinsky","year":"2012","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.jconrel.2023.01.085_bb0170","doi-asserted-by":"crossref","first-page":"10655","DOI":"10.1021\/nn504210g","article-title":"Brain-penetrating nanoparticles improve paclitaxel efficacy in malignant glioma following local administration","volume":"8","author":"Nance","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.01.085_bb0175","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s11095-022-03222-0","article-title":"Effect of particle size and surface charge on nanoparticles diffusion in the brain white matter","author":"Yuan","year":"2022","journal-title":"Pharm. Res."},{"issue":"149","key":"10.1016\/j.jconrel.2023.01.085_bb0180","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003594","article-title":"A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue","volume":"4","author":"Nance","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2023.01.085_bb0185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejpb.2009.09.003","article-title":"European journal of pharmaceutics and biopharmaceutics drug delivery to the brain using surfactant-coated poly (lactide-co-glycolide) nanoparticles\u00a0: influence of the formulation parameters","volume":"74","author":"Gelperina","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.jconrel.2023.01.085_bb0190","first-page":"241","article-title":"PLA \/ PLGA nanoparticles for delivery of drugs across the blood-brain barrier","volume":"2","author":"Li","year":"2013"},{"key":"10.1016\/j.jconrel.2023.01.085_bb0195","series-title":"PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases","first-page":"1","author":"Cunha","year":"2021"},{"key":"10.1016\/j.jconrel.2023.01.085_bb0200","series-title":"Development of Polymeric Nanoparticles for Blood \u2013 Brain Barrier Transfer \u2014 Strategies and Challenges","first-page":"1","volume":"2003937","author":"Zhang","year":"2021"},{"key":"10.1016\/j.jconrel.2023.01.085_bb0205","series-title":"Nanoparticles for Targeted Brain Drug Delivery\u00a0: What Do We Know\u00a0?","author":"Pinheiro","year":"2021"},{"key":"10.1016\/j.jconrel.2023.01.085_bb0210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery\u00a0: overcoming blood \u2013 brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.085_bb0215","series-title":"Polymeric Nanoparticles Drug Delivery to Brain\u00a0: A Review","first-page":"60","author":"Sharma","year":"2015"},{"issue":"February","key":"10.1016\/j.jconrel.2023.01.085_bb0220","first-page":"1","article-title":"Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors","volume":"12","author":"Gagliardi","year":"2021"},{"key":"10.1016\/j.jconrel.2023.01.085_bb0225","article-title":"Jo ur na l P f","author":"Awad","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.01.085_bb0230","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/341848","article-title":"Caffeic acid Phenethyl Ester loaded PLGA nanoparticles: effect of various process parameters on reaction yield, encapsulation efficiency, and particle size","volume":"2015","author":"Derman","year":"2015","journal-title":"J. Nanomater."},{"issue":"4","key":"10.1016\/j.jconrel.2023.01.085_bb0235","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/jps.21158","article-title":"PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug","volume":"97","author":"Sahana","year":"2008","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2023.01.085_bb0240","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jconrel.2007.05.034","article-title":"Effect of acidic pH on PLGA microsphere degradation and release","volume":"122","author":"Zolnik","year":"2007","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2023.01.085_bb0245","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-8140(86)80005-6","article-title":"pH-induced modification of BCNU toxicity on glial cells","volume":"5","author":"R\u00f6ttinger","year":"1986","journal-title":"Radiother. Oncol."},{"issue":"4","key":"10.1016\/j.jconrel.2023.01.085_bb0250","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s11705-021-2067-5","article-title":"Long acting carmustine loaded natural extracellular matrix hydrogel for inhibition of glioblastoma recurrence after tumor resection","volume":"16","author":"Chen","year":"2022","journal-title":"Front. Chem. Sci. Eng."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923000949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923000949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:43:53Z","timestamp":1759164233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923000949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":50,"alternative-id":["S0168365923000949"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.085","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracranial nanomedicine-gel with deep brain-penetration for glioblastoma therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}